Vitamin D Research

back to research menu

Heart Disease

• Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: Interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol. 2008 Aug 20;590(1–3):290–6.
• Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol. 2008 Aug 14.
• Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008 Aug;19(8):1509–19.
• Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144–51.
• 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).Am J Kidney Dis. 2007 Jul;50(1):69–77.
• Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States.Arch Intern Med. 2007 Jun 11;167:1159–1165.
• Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
• Hypocalcemia as a Cause of Reversible Cardiomyopathy with Ventricular Tachycardia.Ann Intern Med. 3 April 2007 | Volume 146 Issue 7 | Pages 541–542.
• Effects of atorvastatin on vitamin d levels in patients with acute ischemic heart disease.Am J Cardiol. 2007 Apr 1;99(7):903–5.
• Vitamin D supplementation and cardiovascular disease risk.Circulation. 2007 Feb 20;115(7):827–8. Editorial.
• Calcium/vitamin D supplementation and cardiovascular events.Circulation. 2007 Feb 20;115(7):846–54.
• Vitamin D and vascular calcification.Curr Opin Lipidol. 2007 Feb;18(1):41–6. Review.
• Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study.J Clin Endocrinol Metab. 2007 Vol. 92, No. 8 3068–3075.
• Relationships between Myocardial Injury, All-cause Mortality, Vitamin D, PTH, and Biochemical Bone Turnover Markers in Older Patients with Hip Fractures.Annals of Clinical and Laboratory Science 37:222–232 (2007).
• Micronutrients in African-Americans with decompensated and compensated heart failure.Transl Res. 2006 Dec;148(6):301–8.
• Hypothesis: Correction of low vitamin D status among Arab women will prevent heart failure and improve cardiac function in established heart failure.Eur J Heart Fail. 2006 Nov;8(7):694–6.
• Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients.Clin Endocrinol (Oxf). 2006 Nov;65(5):593–597.
• Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Sep;92(1):39–48. Review.
• Vitamin D deficiency: A global perspective.Arq Bras Endocrinol Metabol. 2006 Aug;50(4):640–6.
• Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells.Atherosclerosis. 2006 May;186(1):20–8.
• Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev. 2006 Mar;11(1):25–33.
• Cardiovascular disease in chronic kidney failure: the role of VDR activators.Curr Opin Investig Drugs. 2006 Mar;7(3):206–13. Review.
• Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure.Am J Med Sci. 2006 Jan;331(1):30–4.
• Kidneys, hearts, hormones and immunomodulators: integrated understandings.Blood Purif. 2006;24(1):46–50. Review.
• Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia.J Biol Chem. 2005 Nov 25;280(47):39394–402.
• Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?Kidney Int. 2005 Nov;68(5):1973–81. Review.
• The role of vitamin D in vascular calcification in chronic kidney disease.Semin Dial. 2005 Jul–Aug;18(4):307–14. Review.
• Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
• Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?J Am Coll Cardiol. 2003 Jan 1;41(1):105–12.
• Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D.Mol Endocrinol. 2002 Jul;16(7):1524–37.
• Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease.Eur J Epidemiol. 2001;17(6):567–71.
• Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction.J Am Coll Cardiol. 1998 May;31(6):1226–33.
• Absence of a seasonal variation in myocardial infarction onset in a region without temperature extremes.Cardiology. 1998 May;89(4):277–82.
• Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997 Sep;103(3):197–207.
• Seasonal pattern of acute myocardial infarction in the National Registry of Myocardial Infarction. J Am Coll Cardiol. 1996 Dec;28(7):1684–8.
• Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.Am J Hypertens. 1995 Sep;8(9):894–901.
• Serum 25-hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforce.Aust N Z J Med. 1995 Jun;25(3):218–23.
• Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population.Ann Epidemiol. 1992 Sep;2(5):697–703.
• Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study.Int J Epidemiol. 1990 Sep;19(3):559–63.
• Changes in plasma vitamin levels in the first 48 hours after onset of acute myocardial infarction.Am J Cardiol. 1989 Nov 1;64(16):971–4.

back to research menu